Application Nr Approved Date Route Status External Links
ANDA091134 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Etodolac Extended-Release Tablets, Usp And Other Treatment Options Before Deciding To Use Etodolac Extended-Release Tablets, Usp. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (See Warnings ). Etodolac Extended-Release Tablets, Usp Are Indicated: * For Relief Of Signs And Symptoms Of Juvenile Arthritis * For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis * For Relief Of The Signs And Symptoms Of Osteoarthritis

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Etodolac ETODOLAC ZINC3642

Comments